A Study to Evaluate the Effect of AB-506 on the Single Dose Pharmacokinetics of an Oral Contraceptive in Healthy Female Subjects
Latest Information Update: 12 Jul 2019
At a glance
- Drugs AB-506 (Primary) ; Drospirenone/ethinylestradiol
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Arbutus Biopharma
- 11 Jul 2019 Status changed from not yet recruiting to completed.
- 26 Mar 2019 New trial record